Ameet Mallik
Chief Executive Officer bei ADC THERAPEUTICS SA
Vermögen: 3 Mio $ am 31.03.2024
Profil
Ameet Mallik is currently the President, Chief Executive Officer & Director at ADC Therapeutics SA since 2022.
He is also an Independent Director at Atara Biotherapeutics, Inc. since 2021.
Previously, he served as the Non-Executive Chairman at Cornerstone Pharmaceuticals, Inc. He was also a Director at Rafael Holdings, Inc. in 2022.
From 2015 to 2017, he was the Global Head-Marketing, Value & Access at Novartis Oncology, Inc. He then became the Executive Vice President & Head-US Oncology at Novartis AG from 2017 to 2021.
Prior to that, he worked as an Associate Principal at McKinsey & Co., Inc. He started his career at Sandoz International GmbH in 2009 as the Head-Biopharmaceuticals & Oncology Injectables until 2014.
Mr. Mallik completed his undergraduate and graduate studies at Northwestern University and holds an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,84% | 01.02.2024 | 696 561 ( 0,84% ) | 3 Mio $ | 31.03.2024 |
| 31.03.2024 | 227 500 ( 0,18% ) | 157 885 $ | 31.03.2024 |
Aktive Positionen von Ameet Mallik
| Unternehmen | Position | Beginn |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Director/Board Member | 09.08.2021 |
| ADC THERAPEUTICS SA | Chief Executive Officer | 09.05.2022 |
Ehemalige bekannte Positionen von Ameet Mallik
| Unternehmen | Position | Ende |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Chief Executive Officer | 01.02.2022 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.11.2015 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | 01.04.2014 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Chairman | - |
Ausbildung von Ameet Mallik
| Northwestern University | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NOVARTIS AG | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| RAFAEL HOLDINGS, INC. | Finance |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
